June 4th, 2021
Intellectual property rights are at the root of biotechnology R&D and vital to the industry in the Bay Area. In an article on Medium.com, Sean Randolph of the Bay Area Council Economic Institute, explains why waiving the intellectual property rights of vaccine producers is not an effective near or long-term strategy.